Circulatory Failure: Causes, Symptoms, and Treatment

Circulatory failure, commonly called shock, occurs when the body can no longer deliver enough oxygen-rich blood to keep organs and tissues alive. It is not a single disease but a collection of conditions that share one deadly problem: the mismatch between how much oxygen cells need and how much they actually receive. The concept has evolved considerably over the past century, moving from a vague description of collapse after trauma to a precise framework organized around oxygen supply and demand.

What Circulatory Failure Actually Means at the Tissue Level

Every cell in your body runs on oxygen. Blood picks up oxygen in the lungs and delivers it through a branching network of arteries and tiny capillaries. Circulatory failure disrupts that delivery chain at one or more points. When oxygen delivery drops below a critical threshold, cells can no longer extract enough oxygen to sustain normal metabolism, and tissues begin to starve. The result is a cascade: cells switch to less efficient energy production, waste products like lactic acid accumulate, and organs start to malfunction.

The mechanisms behind this oxygen shortfall fall into a few broad categories. Circulatory hypoxia (the pump or pipes fail), anemic hypoxia (blood cannot carry enough oxygen), and hypoxic hypoxia (not enough oxygen enters the blood in the first place) all share the feature of reduced delivery with the body still trying to compensate by extracting more oxygen from what blood is available.1PubMed. Pathophysiology, mechanisms, and managements of tissue hypoxia But compensation has limits. Once those limits are exceeded, organs begin to fail in sequence.

One early and often underappreciated part of this process involves the endothelial glycocalyx, a thin gel-like coating on the inside of blood vessels. In trauma and hemorrhagic shock, this lining breaks down, which increases inflammation, makes capillaries leaky, and disrupts the fine-tuned regulation of blood flow at the microscopic level.2PubMed Central. Resuscitating the Endothelial Glycocalyx in Trauma and Hemorrhagic Shock Patients with low plasma protein levels after injury show significantly more glycocalyx shedding, which corresponds to greater vascular leakiness.3PubMed Central. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients This helps explain why some patients continue to deteriorate even when their blood pressure looks reasonable on a monitor.

The Four Types of Shock

Clinicians classify circulatory failure into four main types based on what has gone wrong. The distinction matters because treatments differ sharply. Echocardiography at the bedside can rapidly identify which type a patient is experiencing, since each one leaves a different footprint on heart function and blood flow patterns.4PubMed Central. Echocardiography in shock management

Cardiogenic Shock

When the heart itself fails as a pump, the result is cardiogenic shock. The most common trigger by far is a heart attack: acute myocardial infarction accounts for about 81% of cases.5PubMed Central. Cardiac Failure and Cardiogenic Shock: Insights Into Pathophysiology, Classification, and Hemodynamic Assessment The pathology tends to feed on itself. Damaged heart muscle pumps less effectively, which reduces blood flow to the heart’s own arteries, which worsens the damage. Areas of heart muscle that are stunned but not yet dead can contribute to this downward spiral.6PubMed. Cardiogenic shock As the condition progresses, it stops being purely a pump problem: inflammatory molecules flood the bloodstream, regional blood flow becomes chaotic, and individual cells lose the ability to use oxygen even when it is present.7PubMed Central. Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization

Hypovolemic Shock

Hypovolemic shock results from losing too much blood or fluid. Hemorrhage is the classic cause, whether from trauma, surgery, or a ruptured blood vessel. Rapid and significant blood loss produces a predictable chain of events: blood pressure drops, oxygen delivery falls, tissues become starved, and organ damage accumulates.8PubMed Central. Clinical review: hemorrhagic shock Severe dehydration, burns, and prolonged vomiting or diarrhea can also drain enough fluid volume to trigger this form of shock, though blood loss remains the most dramatic route.

Distributive Shock

In distributive shock the total blood volume may be roughly normal, but the blood vessels dilate so widely that the available volume cannot maintain adequate pressure. It is a state of relative hypovolemia: the tank is the same size, but the pipes have gotten much bigger.9PubMed Central. The Nomenclature, Definition and Distinction of Types of Shock Sepsis is the leading cause, but severe allergic reactions (anaphylaxis) and spinal cord injuries can do the same thing. At the molecular level, the widespread vessel relaxation involves overproduction of nitric oxide, activation of certain potassium channels in blood vessel walls, and a shortage of vasopressin, a hormone that normally helps maintain vascular tone.10PubMed Central. Vasogenic shock physiology

Obstructive Shock

Obstructive shock looks a lot like cardiogenic shock on first glance because the heart’s output drops in both. The difference is that the heart itself is structurally fine; something outside the heart is physically blocking blood flow. The most recognized causes are pulmonary embolism (a clot in the lung arteries), tension pneumothorax (air trapped in the chest compressing the heart), pericardial tamponade (fluid squeezing the heart from outside), and aortic dissection.11PubMed Central. Obstructive Shock, from Diagnosis to Treatment Distinguishing obstructive from cardiogenic shock is critical because the treatments are entirely different: draining fluid from around the heart, for example, versus supporting a failing heart muscle.

Recognizing the Signs

The early symptoms of circulatory failure can be deceptively subtle. A fast heart rate and cool, clammy skin are among the first clues, along with confusion or agitation as the brain gets less oxygen. Blood pressure may remain deceptively normal at first because the body compensates by squeezing blood vessels tighter, which is why clinicians have learned not to rely on blood pressure alone to rule out shock.

One physical sign that has gained attention is skin mottling, a blotchy, lace-like discoloration that usually appears first around the knees. In a large study of patients in cardiogenic shock, nearly 39% had visible mottling at admission. Those who did had a 30-day mortality rate of 31%, compared with about 23% in those without mottling, and the gap widened further at one year.12PubMed Central. Mottling as a prognosis marker in cardiogenic shock Mottling is useful precisely because it requires no equipment: a clinician can see it with their eyes and immediately have meaningful prognostic information.

Other warning signs include a sharp drop in urine output (the kidneys are among the first organs to throttle back when perfusion drops), rapid shallow breathing, and a weak or thready pulse. In distributive shock from sepsis, the skin may paradoxically feel warm early on because vessels are dilated rather than constricted, which can delay recognition.

How Doctors Pinpoint the Problem

Identifying that a patient is in shock is only the first step. Figuring out which type, and how severe, guides every treatment decision that follows.

Blood lactate has become one of the most widely used markers. When tissues do not receive enough oxygen, they produce lactic acid as a byproduct of anaerobic metabolism. Higher initial lactate levels predict worse outcomes, and the speed at which lactate clears after treatment begins, known as lactate kinetics, is equally important. Patients whose lactate dropped by more than about 38% within the first six hours had significantly better survival.13PubMed. Blood lactate and lactate kinetics as treatment and prognosis markers for tissue hypoperfusion Tracking lactate over time gives clinicians a real-time readout of whether their interventions are actually restoring oxygen to tissues.

Central venous oxygen saturation, measured from a catheter placed in a large vein near the heart, provides another window. It reflects how much oxygen is left in the blood after the body has extracted what it needs. When combined with lactate measurements, these two markers together give emergency physicians a clearer picture of the underlying problem than either one alone, allowing more targeted therapy.14PubMed. Optimizing oxygen delivery in the critically ill: the utility of lactate and central venous oxygen saturation (ScvO2) as a roadmap of resuscitation in shock Low central venous oxygen saturation during and after major surgery has also been linked to a higher risk of postoperative complications, making it a useful warning flag beyond the emergency department.15PubMed Central. Multicentre study on peri- and postoperative central venous oxygen saturation in high-risk surgical patients

Bedside ultrasound has transformed how quickly doctors can sort out the cause of shock. An echocardiography-based protocol showed high accuracy in identifying the specific type of shock in the emergency department, functioning as a rapid, non-invasive diagnostic tool.16PubMed Central. Accuracy of echocardiography and ultrasound protocol to identify shock etiology in emergency department Within minutes, a trained clinician can see whether the heart is squeezing poorly (cardiogenic), whether the chambers are underfilled (hypovolemic), whether fluid is compressing the heart from outside (obstructive), or whether the vessels are dilated with normal heart function (distributive).4PubMed Central. Echocardiography in shock management

Treatment Strategies

Treatment for circulatory failure centers on restoring oxygen delivery to tissues as fast as possible, but the approach depends entirely on which type of shock is present.

Fluid Resuscitation

Intravenous fluids are the first-line treatment for hypovolemic shock and play a supporting role in other types. The challenge is giving enough to restore blood volume without overdoing it, because excess fluid can worsen organ function, particularly in the lungs. Using dynamic measures of fluid responsiveness, such as watching how stroke volume changes with a small fluid challenge or a passive leg raise, helps clinicians decide who will actually benefit from more fluid. A meta-analysis of patients with sepsis and septic shock found that guiding fluids with these dynamic measures reduced 28-day mortality by roughly 39%, cut the risk of acute kidney injury by about a third, and resulted in patients accumulating nearly 1.6 liters less excess fluid by day three compared with standard approaches.17PubMed Central. Dynamic Measures of Fluid Responsiveness to Guide Resuscitation in Patients With Sepsis and Septic Shock: A Systematic Review and Meta-Analysis

Vasopressors and Inotropes

When fluids alone cannot maintain adequate blood pressure, vasopressors (drugs that tighten blood vessels) and inotropes (drugs that strengthen the heart’s squeeze) enter the picture. In septic shock, norepinephrine is the go-to first-line vasopressor. Starting it early helps patients reach safe blood-pressure targets faster and reduces the risk of fluid overload from giving too much IV fluid while waiting for pressure to improve.18PubMed Central. Vasopressors in septic shock: which, when, and how much?

For cardiogenic shock, the picture is more nuanced. Dobutamine and milrinone are the two most commonly used inotropes, and clinicians have debated for years which is better. A randomized trial comparing the two in cardiogenic shock found no significant difference in outcomes: a composite of death, cardiac arrest, need for mechanical support, or dialysis occurred in 49% of milrinone patients and 54% of dobutamine patients, a gap that was not statistically meaningful. In-hospital death rates were similarly close at 37% and 43%, respectively.19New England Journal of Medicine. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock Those numbers also underscore a sobering reality: even with drug support, cardiogenic shock remains extremely lethal.

Mechanical Circulatory Support

When drugs and fluids are not enough to keep a patient alive, mechanical devices can temporarily take over part or all of the heart’s work. The most widely used is VA-ECMO (venoarterial extracorporeal membrane oxygenation), which pulls blood out of the body, oxygenates it through an artificial lung, and pumps it back in. It buys time, but it comes with a catch: by pushing blood back into the aorta, it can increase the workload on an already failing left ventricle.

To counter that problem, clinicians sometimes add a small catheter-based pump called an Impella, which sits across the aortic valve and actively unloads the left ventricle. Right heart catheterization in patients receiving this combination showed a marked drop in the pressure backing up into the lungs. In one series of 106 patients, about 52% were successfully weaned off mechanical support, and 30-day survival of roughly 36% significantly exceeded what established risk prediction tools had projected.20PubMed. Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock

Whether adding the Impella to ECMO truly improves survival, however, remains contested. One observational study found that the combination (sometimes called ECPELLA) was independently associated with better one-year survival compared with ECMO alone, with a hazard ratio of 0.47 for one-year mortality.21European Heart Journal. Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO But a systematic review and meta-analysis pooling data across multiple studies found no statistically significant difference in early mortality between ECPELLA and ECMO alone. Worse, the combination carried significantly higher rates of hemolysis (destruction of red blood cells), major bleeding, limb ischemia, and need for kidney replacement therapy.22European Heart Journal – Quality of Care and Clinical Outcomes. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis The evidence, in other words, is genuinely conflicted. Single-center studies with selected patients look promising, but the broader data raise real concerns about complications. Randomized trials are still working to settle the question.

Why Fixing the Big Numbers Is Not Always Enough

One of the most important lessons in shock medicine over the past two decades is that restoring normal-looking vital signs on a monitor does not guarantee that tissues are actually receiving oxygen. Blood pressure, heart rate, and cardiac output are all measurements of the large-scale circulation, the macrocirculation. But oxygen is ultimately exchanged in capillaries, the microscopic vessels where blood actually meets tissue cells. And the behavior of those tiny vessels does not always follow what the big vessels are doing.

This disconnect is called a loss of hemodynamic coherence. Even after blood pressure and cardiac output are restored to normal ranges, microcirculatory flow can remain deranged, with capillaries plugged by swollen cells, shunting blood past tissue beds, or leaking fluid into surrounding tissue. Each of these problems limits oxygen delivery at the cellular level despite what the bedside monitor says.23PubMed Central. Hemodynamic coherence and the rationale for monitoring the microcirculation Research in sepsis has been particularly revealing on this point, showing that optimizing large-vessel hemodynamics may not improve microvascular perfusion at all.24PubMed Central. Microcirculation-guided resuscitation in sepsis: the next frontier?

This is one reason why some patients die of organ failure even after their blood pressure and lab values seem to normalize. The macro numbers look fine, but the micro circulation never recovered. Integrating microvascular monitoring into routine shock management is an active area of research, though it has not yet become standard practice.

When Multiple Organs Fail

The longer circulatory failure persists, the more organs get dragged into the crisis. Kidneys, liver, lungs, and brain are all vulnerable, and the more organs that fail, the worse the prognosis becomes. In a retrospective study of 354 patients on extracorporeal life support, each additional organ that developed dysfunction significantly prolonged the time patients needed mechanical support and worsened survival. Liver dysfunction had the strongest independent effect on mortality, more than doubling the odds of death. Inflammatory markers in the blood rose significantly with each additional organ affected, reflecting the systemic inflammatory storm that accompanies multi-organ failure.25Wiley Online Library (Artificial Organs). Multi-organ dysfunction syndrome in patients undergoing extracorporeal life support

This cascade helps explain why early, aggressive treatment of shock is so important. Once two or three organ systems are failing simultaneously, each treatment decision becomes a trade-off: fluids that help the circulation may harm the lungs; drugs that support blood pressure may reduce blood flow to the kidneys; mechanical support devices may cause bleeding or damage to red blood cells. The window for clean, uncomplicated intervention narrows rapidly.

Machine Learning and Early Warning

One of the most promising frontiers in managing circulatory failure is catching it before it fully develops. Traditional monitoring relies on setting alarm thresholds for individual vital signs, such as alerting when blood pressure drops below a certain point. The problem is that by the time a single parameter crosses a threshold, the patient may already be deep into shock. These threshold-based alarms also generate enormous numbers of false alerts, which leads to alarm fatigue among ICU staff.

A machine-learning model trained on a high-resolution database encompassing 240 patient-years of ICU data took a different approach. Instead of watching one number at a time, it integrated measurements from multiple organ systems simultaneously. The system predicted 90% of circulatory-failure events in the test set, with 82% of those predictions made more than two hours before the event occurred. It achieved an area under the receiver operating characteristic curve of 0.94, meaning it was highly accurate at distinguishing real deterioration from noise. And it generated only 0.05 alarms per patient per hour, far fewer false alarms than conventional systems. The model was also validated in an independent patient group, suggesting its performance was not just an artifact of the training data.26PubMed. Early prediction of circulatory failure in the intensive care unit using machine learning

Two hours of advance warning may not sound like much, but in an ICU it can be the difference between starting vasopressors before the blood pressure crashes and scrambling to catch up after it has. Whether these tools improve actual patient outcomes when deployed in real clinical settings is the next question being studied, but the potential to shift shock management from reactive to preventive is real.

How the Definition of Shock Has Changed

The word “shock” originally described the visible collapse of wounded soldiers, a descriptive label for something clinicians could see but not explain. Over the following century, the understanding evolved through stages: traumatic shock, wound shock, septic shock, cardiogenic shock, each recognized as its own entity with its own treatment. Classification systems and pathogenic theories were constantly revised as monitoring technology improved, from crude blood-pressure cuffs to continuous cardiac output monitoring to the microcirculatory imaging tools now entering clinical practice.27PubMed. The history and evolution of circulatory shock The modern definition centers on oxygen supply-demand imbalance, which is a more useful framework than any purely descriptive label because it directly points toward what treatment needs to accomplish. It also means that shock is no longer a single syndrome but a family of conditions united by a shared physiological endpoint: tissues running out of oxygen.